Vazegepant hydrochloride T8682
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
CAS nr:
1414976-20-7
Purity:
98%
Molecular Weight:
675,3
SMILES:
Cl.CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](Cc1cc(C)c2[nH]ncc2c1)NC(=O)N1CCC(CC1)c1cc2ccccc2[nH]c1=O
Formula:
C36H47ClN8O3
Pathway:
Membrane transporter/Ion channel,Others
Target:
CGRP Receptor,Others
